Pitogo, Mark Jasper V.

HRN: 25-69-30  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/02/2024
09/08/2024
TIV
300mg
Q6
S/P ORIF Of Mandibular Area Using Titanium
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: